Understanding the critical shift from manual safety to automated infection control.
Auto-disable (AD) syringes are the frontline defense against cross-contamination and the reuse of medical devices. In global immunization programs, AD technology is mandated by the WHO to prevent the spread of blood-borne pathogens like HIV and Hepatitis B/C.
Modern AD syringes utilize a fixed-needle design or a plunger-lock system. Once the full dose is administered, the internal mechanism triggers a physical break or lock, rendering the syringe inoperable for a second use.
By migrating to AD technology, healthcare systems reduce the risk of accidental needle-stick injuries by up to 85%, ensuring a safer environment for both practitioners and patients in high-density clinic settings.
Driving the next generation of safe injection systems through AI and material science.
The industry is currently transitioning from passive AD mechanisms to active safety systems. Our R&D focuses on three pillars:
How Hangzhou JZCare Medical Co., Ltd. redefines medical manufacturing efficiency.
Hangzhou JZCare Medical Co., Ltd. is a professional medical consumables manufacturer specializing in disposable medical syringes, sterile injection devices, and high-quality healthcare disposable products for global medical markets. Established in 2011 and located in Hangzhou, China, the company integrates research and development, precision injection molding, automated production, sterilization processing, and global OEM/ODM services.
Our facility utilizes high-speed electric injection molding machines that ensure tolerances within microns, essential for the delicate locking mechanisms of AD syringes.
Human contact is minimized through Class 100,000 cleanroom automation, reducing bio-burden and ensuring 100% consistency across billions of units.
Located in the heart of China's medical hub, we leverage localized raw material sourcing to mitigate global logistics volatility and maintain competitive pricing.
JZCare operates a modern manufacturing facility covering approximately 26,000 square meters with more than 300 employees, including experienced engineers, quality inspectors, and production specialists. The factory is equipped with advanced cleanroom workshops, fully automated assembly lines, and strict quality control systems to ensure product safety, consistency, and compliance with international medical standards.
Navigating the complex regulatory landscape of international medical markets.
For global enterprises, procurement isn't just about price; it's about Compliance (E-E-A-T). JZCare ensures that every Syringe with Auto-Disable feature meets the following benchmarks:
A transparent look into our world-class manufacturing environment.
Addressing the strategic concerns of healthcare distributors and procurement officers.
The standard syringe can theoretically be cleaned and reused, posing a massive infection risk. An AD (Auto-Disable) syringe contains an internal locking mechanism that activates automatically after the delivery of the intended dose, making it impossible to pull back the plunger or reuse the needle.
We utilize an Integrated Quality Management System (IQMS) where every batch undergoes physical stress testing, sterilization efficacy verification, and leak testing. Our annual capacity of 1.5 billion units is supported by real-time monitoring of assembly line precision.
Yes. Through our OEM/ODM services, we can customize needle gauges, barrel markings (e.g., fixed doses like 0.1ml for BCG or 0.5ml for COVID-19 vaccines), and packaging styles to meet the specific requirements of regional health ministries.
Typically, our sterile medical syringes have a shelf life of 5 years, provided they are stored in a cool, dry place away from direct sunlight. The EO sterilization remains valid as long as the primary packaging remains uncompromised.
JZCare Syringe
